The human epidermal growth factor receptor 2 (HER2 or erbB-2/neu) is a well-known oncogene and an important biomarker in breast cancer, especially in HER2-positive subset, where several targeted agents have been approved in recent years (3). Here, ERBB2 is linked to breast cancer.